Similar articles

• The effects of 6-hydroxydopamine pretreatment on the accumulation of dopa and dopamine in brain and peripheral organs following L-dopa administration.

  Lytle LD, Hurko O, Romero JA, Cottman K, Leehey D, Wurtman RJ. Lytle LD, et al. J Neural Transm. 1972;33(1):63-71. doi: 10.1007/BF01244728. J Neural Transm. 1972. PMID: 4641868 No abstract available.
• Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.

  Schoenfeld RI, Uretsky NJ. Schoenfeld RI, et al. J Pharmacol Exp Ther. 1973 Sep;186(3):616-24. J Pharmacol Exp Ther. 1973. PMID: 4728340 No abstract available.
• L-dopa in Parkinsonism. A possible mechanism of action.

  Ng LK, Chase TN, Colburn RW, Kopin IJ. Ng LK, et al. Neurology. 1972 Jul;22(7):688-96. doi: 10.1212/wnl.22.7.688. Neurology. 1972. PMID: 4673250 No abstract available.
• Short- and long-term regulation of tyrosine hydroxylase.

  Costa E, Guidotti A, Zivkovic B. Costa E, et al. Adv Biochem Psychopharmacol. 1974;12(0):161-75. Adv Biochem Psychopharmacol. 1974. PMID: 4154019 Review. No abstract available.
• Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.

  Cooper BR, Breese GR. Cooper BR, et al. Adv Biochem Psychopharmacol. 1974;12(0):353-68. Adv Biochem Psychopharmacol. 1974. PMID: 4609223 Review. No abstract available.